Tizona Therapeutics is an immunology company which develops treatments for cancer and autoimmune diseases. Its main products are anti-ccr4 antibody for the treatment of cancer and IL-35 agonists for the treatment of autoimmune diseases.
Type | Private | |
Founded | 2014 | |
HQ | South San Francisco, CA, US | Map |
Website | tizonatx.com |
Employees (est.) (Jan 2021) | 38 | |
Cybersecurity rating | A | More |
Founding Date | 2014 |
Tizona Therapeutics total Funding | $70 m |
Tizona Therapeutics latest funding size | $43 m |
Time since last funding | 5 years ago |
Tizona Therapeutics investors | Canaan Partners, InterWest Partners, MPM Capital, Astellas Venture Management, Abingworth, Amgen Ventures, Lightstone Ventures |
Tizona Therapeutics has 102 Twitter Followers. The number of followers has decreased 0.7% month over month and increased 0.1% quarter over quarter
When was Tizona Therapeutics founded?
Tizona Therapeutics was founded in 2014.
Who are Tizona Therapeutics key executives?
Tizona Therapeutics's key executives are Courtney Beers, Christine O'Brien and John Corbin.
How many employees does Tizona Therapeutics have?
Tizona Therapeutics has 38 employees.
Who are Tizona Therapeutics competitors?
Competitors of Tizona Therapeutics include Azeria Therapeutics, Pinteon Therapeutics and Talaris Therapeutics.
Where is Tizona Therapeutics headquarters?
Tizona Therapeutics headquarters is located at 4000 Shoreline Ct #200South, South San Francisco.
Where are Tizona Therapeutics offices?
Tizona Therapeutics has an office in South San Francisco.
How many offices does Tizona Therapeutics have?
Tizona Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies